A new approach to treating vascular blockages has been developed to overcome the limitations of current thrombolytic therapies. This approach involves biosafety and multimodal plasma-derived theranostic platelet vesicle incorporating iron oxide constructed nano-propellers platformed technology that possesses fluorescent and magnetic features and manifold thrombus targeting modes. The platform is capable of being guided and visualized remotely to specifically target thrombi, and it can be activated using near-infrared phototherapy along with an actuated magnet for magnetotherapy. In a murine model of thrombus lesion, this proposed multimodal approach showed an approximately 80 % reduction in thrombus residues. Moreover, the new strategy not only improves thrombolysis but also boosts the rate of lysis, making it a promising candidate for time-sensitive thrombolytic therapy.

Original languageEnglish
Article number100876
JournalMaterials Today Bio
Publication statusPublished - Dec 2023


  • Cold atmospheric plasma
  • Iron oxide
  • Magnetotherapy
  • Phototherapy
  • Platelet vesicle
  • Thrombolysis

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Biomaterials
  • Biomedical Engineering
  • Molecular Biology
  • Cell Biology


Dive into the research topics of 'Cold atmospheric plasma-enabled platelet vesicle incorporated iron oxide nano-propellers for thrombolysis'. Together they form a unique fingerprint.

Cite this